Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0)...

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• The replication error (RER) phenotype is a genetic instability marker observed in various cancers.
• Understanding RER's association with clinical features and genetic alterations is crucial for colorectal cancer prognosis.

Purpose of the Study:

• To investigate the relationship between the RER phenotype and genetic events, clinical features, and survival in stage II colorectal cancer patients.
• To determine if RER status impacts patient outcomes in Dukes' B colorectal cancer.

Main Methods:

• Investigated RER phenotype in 159 colorectal cancer patients using PCR amplification of microsatellite markers.
• Analyzed data on c-Ki-ras mutations, p53, and c-erbB-2 expression.
• Performed univariate and multivariate survival analyses.

Main Results:

• 14% of colorectal cancers were RER+; these tumors were more often right-sided, larger, and poorly differentiated.
• No significant association was found between RER status and c-Ki-ras mutations, p53, c-erbB-2, or c-myc expression.
• Both univariate and multivariate analyses indicated similar long-term survival for RER+ and RER- patients.

Conclusions:

• The RER phenotype in colorectal cancer is associated with distinct pathological features.
• RER status does not appear to be a significant prognostic factor for long-term survival in stage II colorectal cancer.
• RER phenotype is not significantly associated with the genetic alterations (c-Ki-ras, p53, c-erbB-2, c-myc) investigated in this study.